Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/BIOCRYST-PHARMACEUTICALS--8534/news/BioCryst-Announces-FDA-Approval-of-ORLADEYO-berotralstat-First-Oral-Once-daily-Therapy-to-Pre-31934894/?utm_source=whatsapp&utm_medium=social&utm_campaign=share